A Point-of-Care Paper-based Fingerstick Transaminase Test: Toward Low-cost "Lab-on-a-Chip" Technology for the Developing World

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 5, 2013, Pages 478-482

  Pollock, Nira R ^a,b   Colby, Donn ^a,c   Rolland, Jason P ^d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Diagnostics for All   (United States)

Author keywords

Diagnostic; Fingerstick; Microfluidic; Paper; Point of Care; Transaminase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COST UTILITY ANALYSIS; DIAGNOSTIC VALUE; HEALTH CARE COST; HUMAN; LAB ON A CHIP; POINT OF CARE TESTING; TOXIC HEPATITIS;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD CHEMICAL ANALYSIS; DEVELOPING COUNTRIES; HEPATITIS; HUMANS; POINT-OF-CARE SYSTEMS; SPECIMEN HANDLING;

EID: 84876720239     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.02.022     Document Type: Article

References (31)

1. Saukkonen J.J., Cohn D.L., Jasmer R.M., et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006, 174:935-952.
2. Panel on Antiretroviral Guidelines for Adults and Adolescents: guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents-Department of Health and Human Services 1-161 Accessed December 28, 2012. http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf.
3. Shieh F.K., Snyder G., Horsburgh C.R., et al. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med 2006, 174:717-721.
4. Pollock N.R., Rolland J.P., Kumar S., et al. A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing. Sci Transl Med 2012, 4:152ra29.
5. Martinez A.W., Phillips S.T., Whitesides G.M., et al. Diagnostics for the developing world: microfluidic paper-based analytical devices. Anal Chem 2010, 82:3-10.
6. Martinez A.W., Phillips S.T., Carrilho E., et al. Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis. Anal Chem 2008, 80:3699-3707.
7. Martinez A.W., Phillips S.T., Butte M.J., et al. Patterned paper as a platform for inexpensive, low-volume, portable bioassays. Angew Chem Int Ed Engl 2007, 46:1318-1320.
8. Martinez A.W., Phillips S.T., Whitesides G.M. Three-dimensional microfluidic devices fabricated in layered paper and tape. Proc Natl Acad Sci U S A 2008, 105:19606-19611.
9. Cheng C.M., Martinez A.W., Gong J., et al. Paper-based ELISA. Angew Chem Int Ed Engl 2010, 49:4771-4774.
10. Nie Z., Deiss F., Liu X., et al. Integration of paper-based microfluidic devices with commercial electrochemical readers. Lab Chip 2010, 10:3163-3169.
11. Osborn J.L., Lutz B., Fu E., et al. Microfluidics without pumps: reinventing the T-sensor and H-filter in paper networks. Lab Chip 2010, 10:2659-2665.
12. Fu E., Lutz B., Kauffman P., et al. Controlled reagent transport in disposable 2D paper networks. Lab Chip 2010, 10:918-920.
13. Lutz B.R., Trinh P., Ball C., et al. Two-dimensional paper networks: programmable fluidic disconnects for multi-step processes in shaped paper. Lab Chip 2011, 11:4274-4278.
14. Fu E., Kauffman P., Lutz B., et al. Chemical signal amplification in two-dimensional paper networks. Sens Actuators B Chem 2010, 149:325-328.
15. Khan M.S., Thouas G., Shen W., et al. Paper diagnostic for instantaneous blood typing. Anal Chem 2010, 82:4158-4164.
16. Li X., Tian J., Garnier G., et al. Fabrication of paper-based microfluidic sensors by printing. Colloids Surf B Biointerfaces 2010, 76:564-570.
17. Dungchai W., Chailapakul O., Henry C.S. Use of multiple colorimetric indicators for paper-based microfluidic devices. Anal Chim Acta 2010, 674:227-233.
18. Fenton E.M., Mascarenas M.R., Lopez G.P., et al. Multiplex lateral-flow test strips fabricated by two-dimensional shaping. ACS Appl Mater Interfaces 2009, 1:124-129.
19. Vella S.J., Beattie P., Cademartiri R., et al. Measuring markers of liver function using a micropatterned paper device designed for blood from a fingerstick. Anal Chem 2012, 84:2883-2891.
20. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: recommendations for a public health approach, 2010 revision 2010, World Health Organization, World Health Organization, Geneva, Switzerland.
21. Table of grading severity of adult adverse experiences 1996, AIDS Clinical Trials Group, Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, MD.
22. Meintjes G., Maartens G., Boulle A., et al. Guidelines for antiretroviral therapy in adults. S Afr J HIV Med 2012, 13:114-133.
23. Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis 2007, National AIDS Control Organisation, India Ministry of Health and Family Welfare, Delhi, India.
24. Guidelines on the diagnosis and treatment of HIV/AIDS 2009, Vietnam Ministry of Health, Vietnam Ministry of Health, Hanoi, Vietnam.
25. Treatment of tuberculosis guidelines 2009, World Health Organization, World Health Organization, Geneva, Switzerland. 4th ed.
26. Tostmann A., Boeree M.J., Aarnoutse R.E., et al. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol 2008, 23:192-202.
27. McKoy J.M., Bennett C.L., Scheetz M.H., et al. Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events and Reports (RADAR) project. Drug Saf 2009, 32:147-158.
28. Martínez E., Blanco J.L., Arnaiz J.A., et al. Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS 2001, 15:1261-1268.
29. Shipton L.K., Wester C.W., Stock S., et al. Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana. Int J Tuberc Lung Dis 2009, 13:360-366.
30. Hoffmann C.J., Charalambous S., Thio C.L., et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS 2007, 21:1301-1308.
31. Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection: United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2010, 59:224-229. Centers for Disease Control and Prevention.